NorthWest Biotherapeutics Inc (NWBO)

[Dan88]

Exactly troc. It's one more sign built upon the general understanding or good practice that if the trial failed (I would deem a trial fails if it failed to meet its primary endpoint even later the underlying treatment could be approved from other strong indication), the company should have notified the general public.

Of course the blended blinded data says otherwise;

The revised reordered the endpoint suggests otherwise;

And even the current market cap, despite well undervalued, says otherwise.

GL.